Transmedics Group Inc

TMDX

99.050USD

-3.150-3.08%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

Transmedics Group Inc's Score

Industry at a Glance

Industry Ranking

51 / 208

Overall Ranking

149 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Transmedics Group Inc Highlights

StrengthsRisks

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 150.59% year-on-year.

Fairly Valued

The company’s latest PE is 17.69, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 38.01M shares, decreasing 12.93% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 57.80K shares of this stock.

Analyst Rating

Based on 14 analysts

Buy

Current Rating

161.273

Target Price

+48.07%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Transmedics Group Inc is 7.99, ranking 49 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 160.76M, representing a year-over-year increase of 32.18%, while its net profit experienced a year-over-year increase of 1436.87%.

Score

Industry at a Glance

Previous score

7.99

Change

0



Financials

9.64

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.83

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.32

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.89

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.27

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Transmedics Group Inc is 4.36, ranking 193 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 17.69, which is 11887.21% below the recent high of 2121.04 and 2796.70% above the recent low of -477.16.

Score

Industry at a Glance

Previous score

4.36

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 51/208

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Transmedics Group Inc is 8.29, ranking 50 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 148.50, with a high of 170.00 and a low of 114.00.

Score

Industry at a Glance

Previous score

8.29

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Transmedics Group Inc is 6.66, ranking 90 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 133.87 and the support level at 81.35, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.66

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Transmedics Group Inc is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 111.22%, representing a quarter-over-quarter increase of 1.03%. The largest institutional shareholder is The Vanguard, holding a total of 3.60M shares, representing 10.49% of shares outstanding, with 0.54% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

4.74M

+0.20%

Fidelity Management & Research Company LLC

4.60M

-0.67%

The Vanguard Group, Inc.

Star Investors

3.60M

+0.26%

State Street Investment Management (US)

1.28M

-0.73%

Nomura Investment Management Business Trust

906.27K

-4.81%

Geode Capital Management, L.L.C.

813.57K

+1.11%

Two Sigma Investments, LP

1.06M

+52.85%

Driehaus Capital Management, LLC

738.16K

-13.57%

Hood River Capital Management LLC

678.44K

-0.21%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Transmedics Group Inc is 5.62, ranking 79 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 2.06. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Transmedics Group Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Transmedics Group Inc

TMDX

7.20 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bioventus Inc

BVS

8.28 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.13 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.07 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Edwards Lifesciences Corp

EW

8.05 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment